Paiva, J A <br/><br/>
Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures.  [electronic resource] 

 -  International journal of antimicrobial agents  Oct 2017 
 - 529-535 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1872-7913 
<br/><br/><label>Standard No.: </label>10.1016/j.ijantimicag.2017.05.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Amphotericin B--therapeutic use<br/>Antifungal Agents--therapeutic use<br/>Aspergillus--drug effects<br/>Clinical Decision-Making<br/>Critical Illness<br/>Delayed Diagnosis--mortality<br/>Drug Therapy, Combination<br/>Echinocandins--therapeutic use<br/>Female<br/>Fungal Proteins--therapeutic use<br/>Humans<br/>Intensive Care Units<br/>Invasive Pulmonary Aspergillosis--diagnosis<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Respiratory System--microbiology<br/>Treatment Outcome<br/>Voriconazole--therapeutic use